INTU vs UNH: Which Is the Better Buy?

Side-by-side comparison of Intuit Inc. and UnitedHealth Group Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-11.
Intuit Inc. · Technology
$396.57
+37.7% upside to fair value
High Conviction Grade A-
VS
UnitedHealth Group Incorporated · Healthcare
$304.33
+41.3% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
UNH has more upside to fair value (+41.3%). UNH trades at a lower forward P/E (15.1x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric INTU UNH
Current Price $396.57 $304.33
Fair Value Estimate $546.00 $430.00
Upside to Fair Value +37.7% +41.3%
Market Cap $110.4B $276.2B
Forward P/E 19.5x 15.1x
EV / EBITDA 19.0x 14.3x
Price / Sales 5.9x 0.6x
Price / FCF 18.1x 17.2x
Revenue Growth YoY +15.6% +11.8%
Gross Margin 80.8% 18.5%
Operating Margin 26.1% 4.2%
Return on Equity 19.6% 12.7%
Dividend Yield 1.17% 2.9%
FCF Yield 5.51% 5.82%
Analyst Consensus Buy Buy
Investment Thesis
INTU — Intuit Inc.
Intuit is a near-monopoly financial operating system for 60+ million American households and small businesses. TurboTax handles 40%+ of US e-filed returns; QuickBooks is so deeply embedded in SMB workflows it has become the default accounting standard. The stock has fallen 51% from its 2025 high as markets price in AI disruption that has not materialized at scale and may not, since tax complexity…
UNH — UnitedHealth Group Incorporated
UnitedHealth Group is the world's largest diversified healthcare company, combining the dominant US health insurer UnitedHealthcare with the high-margin Optum services platform spanning care delivery, pharmacy benefits, and data analytics. The stock has fallen roughly 49% from its 2024 peak of $596, driven by elevated medical costs, DOJ antitrust scrutiny, CEO transitions (Brian Thompson's murder…
Accumulation Zones
Metric INTU UNH
Zone Low $410.00 $280.00
Zone High $464.00 $340.00
In Buy Zone? Yes Yes
← INTU Research    UNH Research →    All Research